| | | | | | 1 | | | |
| | | | | | 2 | | | |
| | | | | | 14 | | | |
| | | | | | 21 | | | |
| | | | | | 28 | | | |
| | | | | | 31 | | | |
| | | | | | 34 | | | |
| | | | | | 35 | | | |
| | | | | | 38 | | | |
| | | | | | 39 | | | |
| | | | | | 41 | | | |
| | | | | | 43 | | |
|
Name
|
| |
Class
|
| |
Age
|
| |
Position
|
| |
Director
Since |
| |
Current
Term Expiring |
| |
Expiration
of Term for which Nominated |
|
| Directors/Nominees | | | | | | | | | | | | | | | | | | | |
|
Charles Nearburg(1)(2)
|
| |
I
|
| |
76
|
| | Director | | |
2025
|
| |
2028
|
| |
—
|
|
|
Stuart Kovensky(1)(2)
|
| |
II
|
| |
59
|
| | Director | | |
2024
|
| |
2026
|
| |
2029
|
|
|
Meltem Demirors(1)(2)
|
| |
II
|
| |
39
|
| | Director | | |
2024
|
| |
2026
|
| |
2029
|
|
|
Jonathan Marshall
|
| |
III
|
| |
64
|
| | Director | | |
2024
|
| |
2027
|
| |
—
|
|
|
Robert I. Kauffman
|
| |
III
|
| |
63
|
| |
Chairman and Chief Executive Officer
|
| |
2024
|
| |
2027
|
| |
—
|
|
| | | |
For Fiscal Year ended
December 31, 2025 |
| |
For Fiscal Year Ended
December 31, 2024 |
| ||||||
|
Audit fees(1)
|
| | | $ | 29,500 | | | | | $ | 29,000 | | |
|
Audit-related fees(2)
|
| | | | — | | | | | $ | 11,000 | | |
|
Tax fees(3)
|
| | | | — | | | | | | — | | |
|
All other fees
|
| | | | — | | | | | | — | | |
|
Total fees
|
| | | $ | 29,500 | | | | | $ | 40,000 | | |
| | | |
Class A ordinary shares
|
| |
Class B ordinary shares
|
| | | | |||||||||||||||||||||
|
Name and Address of Beneficial Owner(1)
|
| |
Number of
shares benefically owned |
| |
Approximate
percentage of class |
| |
Number of
shares benefically owned |
| |
Approximate
percentage of class |
| |
Approximate
percentage of ordinary class |
| |||||||||||||||
|
Aldel Investors II LLC(2)(3)
|
| | | | 440,000 | | | | | | * | | | | | | 5,470,714 | | | | | | 88.8% | | | | | | 18.3% | | |
|
Robert I. Kauffman(3)(4)
|
| | | | 440,000 | | | | | | * | | | | | | 5,558,214 | | | | | | 90.2% | | | | | | 18.6% | | |
|
Hassan R. Baqar
|
| | | | — | | | | | | — | | | | | | 70,000 | | | | | | 1.14% | | | | | | * | | |
|
Charles Nearburg
|
| | | | — | | | | | | — | | | | | | 25,000 | | | | | | * | | | | | | * | | |
|
Stuart Kovensky
|
| | | | — | | | | | | — | | | | | | 25,000 | | | | | | * | | | | | | * | | |
|
Jonathan Marshall
|
| | | | — | | | | | | — | | | | | | 25,000 | | | | | | * | | | | | | * | | |
|
Meltem Demirors
|
| | | | — | | | | | | — | | | | | | 25,000 | | | | | | * | | | | | | * | | |
|
All officers, directors and director nominees as a group (6 persons)
|
| | | | 440,000 | | | | | | * | | | | | | 5,728,214 | | | | | | 93.2% | | | | | | 19.2% | | |
| |
EXHIBIT E
[LETTERHEAD OF COMPANY] [INSERT DATE] |
|
| | Proposal 1 — Extension Amendment Proposal | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| | It is resolved, as a special resolution, that the Company’s Amended and Restated Memorandum and Articles of Association be amended to allow the Company to extend the date by which the Company must consummate a business combination from October 23, 2026 (the “Deadline Date”) (the date that is 24 months from the closing date of the Company’s initial public offering of units (the “IPO”)) on a monthly basis up to fifteen times until January 23, 2028 (the “Extended Date”) in accordance with the terms set forth in the Investment Management Trust Agreement, dated October 21, 2024 (the “Trust Agreement”), by and between the Company and Continental Stock Transfer and Company (the “Trustee”). | | | | | ||||||
| | Proposal 2 — Trust Amendment Proposal | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| | It is resolved as a special resolution that the Trust Agreement be amended (i) to allow the Company to extend the date on which the Trustee must liquidate the trust account established by the Company in connection with the IPO (the “trust account”) if the Company has not completed its initial business combination by the Deadline Date, or | | | | | ||||||
| | extended such date on a monthly basis up to fifteen times until the Extended Date by depositing $50,000 into the trust account for each public share that has not been redeemed in accordance with the terms of the Company’s charter for each one-month extension from the Deadline Date to the Extended Date, and (ii) to reduce the amount of interest earned on the trust account that the Company is entitled to withdraw from the trust account to cover liquidation and dissolution expenses from $100,000 to $25,000. | | | | | ||||||
| | Proposal 3 — Director Proposal | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| | Elect two Class II Directors, Stuart Kovensky and Meltem Demirors, to the Board to serve as directors of the Company. | | |
☐
|
| |
☐
|
| |
☐
|
|
| | Proposal 4 — Auditor Proposal | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| | Ratify the selection by our Audit Committee of Fruci & Associates II, PLLC to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. | | |
☐
|
| |
☐
|
| |
☐
|
|
| | Proposal 5 — Adjournment Proposal | | |
FOR
|
| |
AGAINST
|
| |
ABSTAIN
|
|
| | Approve the adjournment of the Extraordinary General Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Extension Amendment Proposal, the Trust Amendment Proposal, the Director Proposal or the Auditor Proposal, which we refer to as the “Adjournment Proposal.” | | |
☐
|
| |
☐
|
| |
☐
|
|
| |
Dated: , 2025
Shareholder’s Signature
|
|
| |
Shareholder’s Signature
|
|